Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eptifibatide vs Abciximab in Primary PCI for STEMI
NCT00426751Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Primary completion
- Dec 2007
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of eptifibatide in ST elevation myocardial infarction (STEMI), sponsored by GSK. Started Oct 2006; status: completed.
02
Drugs
eptifibatide
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00426751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426751.